Pyrrolopyrimidines as CRF antagonists
The compounds of the formula wherein R1, R2, R3, R4, R5 and R6 are as defined herein, are useful in the treatment of stress-related and other diseases. These compounds have corticotropin-releasing factor antagonist activity and as such are of use in the treatment of stress and anxiety related, and other disorders.
Pfizer Inc
A A A C A A A A A C A A A
A61P A61P A61P C07D A61P A61P A61P A61P A61P C07D A61P A61P A61P
inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional
Yuhpyng Liang
Chen